Knut E A Lundin Selected Research

Glutens (Glutelin)

1/2022	Phenotype-Based Isolation of Antigen-Specific CD4+ T Cells in Autoimmunity: A Study of Celiac Disease.
11/2021	Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies.
2/2021	In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten Challenge.
1/2021	Comprehensive Analysis of CDR3 Sequences in Gluten-Specific T-Cell Receptors Reveals a Dominant R-Motif and Several New Minor Motifs.
1/2021	A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation.
1/2021	Differential expression profile of gluten-specific T cells identified by single-cell RNA-seq.
1/2021	Nutritional quality and costs of gluten-free products: a case-control study of food products on the Norwegian marked.
1/2021	Machine Learning Analysis of Naïve B-Cell Receptor Repertoires Stratifies Celiac Disease Patients and Controls.
1/2021	A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
1/2021	Frequency of Gluten-Reactive T Cells in Active Celiac Lesions Estimated by Direct Cell Cloning.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Knut E A Lundin Research Topics

Disease

59	Celiac Disease (Celiac Sprue) 10/2022 - 09/2002
10	Inflammation (Inflammations) 02/2021 - 08/2003
4	Atrophy 01/2021 - 10/2004
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020 - 06/2011
4	Crohn Disease (Crohn's Disease) 10/2020 - 11/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2015
3	Wheat Hypersensitivity (Wheat Allergy) 01/2019 - 10/2012
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 10/2022 - 03/2017
2	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 01/2019
2	Dermatitis Herpetiformis (Disease, Duhring's) 01/2019 - 11/2003
2	Ulcerative Colitis 01/2018 - 10/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2021
1	Coinfection 07/2021
1	COVID-19 07/2021
1	Immune System Diseases (Immune Disorders) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2020
1	Infections 02/2019
1	Virus Diseases (Viral Diseases) 02/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Ataxia (Dyssynergia) 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Ankle Fractures 10/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Rheumatoid Arthritis 10/2017
1	Psoriatic Arthritis 10/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2015
1	Sclerosing Cholangitis 05/2015
1	Cholangiocarcinoma 05/2015
1	Neoplasms (Cancer) 08/2014
1	Anemia 04/2014
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2005
1	Tetraploidy 02/2005
1	Osteoporosis 11/2003

Drug/Important Bio-Agent (IBA)

47	Glutens (Glutelin)IBA 01/2022 - 09/2002
14	Peptides (Polypeptides)IBA 01/2021 - 08/2003
13	Protein Glutamine gamma Glutamyltransferase 2IBA 10/2021 - 08/2003
9	HLA-DQ Antigens (HLA-DQ)IBA 01/2022 - 02/2007
9	AntigensIBA 01/2022 - 02/2012
9	EpitopesIBA 01/2022 - 06/2013
7	Immunoglobulin A (IgA)IBA 09/2022 - 02/2012
6	AntibodiesIBA 09/2022 - 01/2015
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2020
5	EnzymesIBA 04/2019 - 02/2012
4	AutoantibodiesIBA 01/2019 - 02/2012
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2003
3	HLA Antigens (Human Leukocyte Antigens)IBA 11/2020 - 02/2012
3	TransglutaminasesIBA 04/2019 - 02/2012
3	CytokinesIBA 01/2019 - 05/2013
3	AutoantigensIBA 01/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 09/2022 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 05/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Infliximab (Remicade)FDA Link 10/2020 - 01/2018
2	ProlaminsIBA 01/2020 - 10/2004
2	GliadinIBA 11/2015 - 02/2005
2	HLA-DQ8 antigenIBA 02/2012 - 08/2006
2	Indicators and Reagents (Reagents)IBA 06/2011 - 02/2007
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2006 - 02/2005
1	MonosaccharidesIBA 10/2022
1	ParaffinIBA 02/2021
1	Formaldehyde (Formol)FDA Link 02/2021
1	ProteomeIBA 02/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	ChromatinIBA 01/2021
1	ZED1227IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	CT-P13IBA 10/2020
1	SuspensionsIBA 04/2019
1	Adalimumab (Humira)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	Tumor Necrosis Factor InhibitorsIBA 10/2017
1	Fructans (Levans)IBA 03/2017
1	SteroidsIBA 01/2017
1	vedolizumabIBA 01/2017
1	IntegrinsIBA 01/2017
1	Monoclonal AntibodiesIBA 11/2015
1	Biosimilar PharmaceuticalsIBA 04/2014
1	IronIBA 04/2014
1	Hemoglobins (Hemoglobin)IBA 04/2014
1	HLA-DQ9 antigenIBA 04/2012
1	Aspartic Acid (Aspartate)FDA Link 04/2012
1	Xylose (D-Xylose)FDA Link 11/2010
1	Chemokine ReceptorsIBA 06/2007

Therapy/Procedure

13	Gluten-Free Diet 10/2022 - 11/2003
5	Therapeutics 11/2021 - 11/2003
1	Immunotherapy 11/2021
1	Fecal Microbiota Transplantation 01/2020
1	Pancreaticoduodenectomy 04/2019
1	Stem Cell Transplantation 01/2017
1	Liver Transplantation 03/2012
1	Diet Therapy (Therapy, Diet) 11/2003